Get started
Author

Stephanie Mayer

Observed names: Mayer, Stephanie, S Mayer, S. Mayer, Stephanie B. Mayer, Stéphanie B Mayer, Stéphanie B. Mayer
Observed institutions: Pennington Biomedical Research Center, Louisiana State University, United States Department of Veterans Affairs, Virginia Commonwealth University, Hebrew University of Jerusalem, Heidelberg University, Veterans Health Administration, Hadassah Medical Center, Hunter Holmes McGuire VA Medical Center, Sykehuset i Vestfold, University Hospital Regensburg, Duke Medical Center, Høgskulen i Sogn og Fjordane, University of Regensburg, Virginia Commonwealth University Medical Center
ORCID: 0000-0003-2437-347X
Observed ORCID: 0000-0003-2437-347X
OpenAlex ID: A5063558334
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
1997 · C Scheibenbogen, K H Lee, et al. · PubMed · 124
Conflicting Results Between Randomized Trials and Observational Studies on the Impact of Proton Pump Inhibitors on Cardiovascular Events When Coadministered With Dual Antiplatelet Therapy
2015 · Chiara Melloni, Jeffrey B. Washam, et al. · Circulation Cardiovascular Quality and Outcomes · 122
PDF
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas
2021 · Nora Liebers, Johannes Duell, et al. · Blood Advances · 96
PDF
The Treatment of Patients With Disseminated Malignant Melanoma by Vaccination With Autologous Cell Hybrids of Tumor Cells and Dendritic Cells
2002 · Stefan W. Krause, Christine Neumann, et al. · Journal of Immunotherapy · 78
Analysis of the Immune Response against Tetanus Toxoid: Enumeration of Specific T Helper Cells by the Elispot Assay
2002 · Stephanie Mayer, Monika Laumer, et al. · Immunobiology · 52
Effect of Allowing Choice of Diet on Weight Loss
2015 · William S. Yancy, Stephanie B. Mayer, et al. · Annals of Internal Medicine · 50
Clinical associations of an updated medication effect score for measuring diabetes treatment intensity
2019 · Anastasia-Stefania Alexopoulos, William S Yancy, et al. · Chronic Illness · 44
Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
2015 · Stéphanie B Mayer, William S Evans, et al. · Women s Health · 43
PDF
Systemic therapy of necrobiotic xanthogranuloma: a systematic review
2022 · Lisa Steinhelfer, Thomas Kühnel, et al. · Orphanet Journal of Rare Diseases · 32
PDF
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients
2017 · Marina Hierl, Jochen Pfirstinger, et al. · Oncology · 24
Factors associated with choice of a low-fat or low-carbohydrate diet during a behavioral weight loss intervention
2014 · Megan A. McVay, Corrine I. Voils, et al. · Appetite · 18
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides
1996 · S. Mayer, C. Scheibenbogen, et al. · Journal of Immunological Methods · 18
Overweight BMI (25–29) in Active Duty Military: Excess Fat or More Lean Mass? A Look at the Evidence
2021 · Philip G Clerc, Stéphanie B Mayer, et al. · Military Medicine · 14
Tafasitamab and Lenalidomide in Relapsed/Refractory B-Cell Lymphoma: A Multicenter Retrospective Real-World-Study of Patients from Germany and Austria
2023 · Anna Ruckdeschel, Koemm Sabrina, et al. · Blood · 10
Considering patient diet preference to optimize weight loss: Design considerations of a randomized trial investigating the impact of choice
2013 · William S. Yancy, Cynthia J. Coffman, et al. · Contemporary Clinical Trials · 10
R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG
2023 · Gerhard Held, Bettina Altmann, et al. · Blood · 9
Food preferences and weight change during low-fat and low-carbohydrate diets
2016 · Megan A. McVay, Corrine I. Voils, et al. · Appetite · 7
Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review
2014 · Jeffrey B. Washam, Rowena J. Dolor, et al. · Journal of Thrombosis and Thrombolysis · 7
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
2022 · Roch Houot, Viola Poeschel, et al. · HemaSphere · 6
Biomodulatory therapy approach with lenalidomide in combination with pioglitazone, dexamethasone, and metronomic low-dose chemotherapy with treosulfan in patients with relapsed/refractory multiple myeloma > second-line.
2019 · Daniel Heudobler, Tanja Elger, et al. · Journal of Clinical Oncology · 6
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma
2022 · Matthias A. Fante, Mona Felsenstein, et al. · Frontiers in Oncology · 5
PDF
Obese Veterans Enrolled in a Veterans Affairs Medical Center Outpatient Weight Loss Clinic Are Likely to Experience Disordered Sleep and Posttraumatic Stress
2016 · Stephanie B. Mayer, James R. Levy, et al. · Journal of Clinical Sleep Medicine · 5
Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers
2025 · Giulia Magno, Kai Rejeski, et al. · Blood Advances · 3
PDF
159 | R‐pola‐glo – Chemo‐light Frontline Therapy Induces High Response Rates With a Favorable Safety Profile in Elderly/frail Patients With Aggressive Lymphoma
2025 · R. Wurm‐Kuczera, T. Melchardt, et al. · Hematological Oncology · 3
PDF
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma
2023 · Matthias A. Fante, Dennis C. Harrer, et al. · Frontiers in Oncology · 3
PDF
Works count: 46
Citation count: 802
H-index: 13
I10-index: 15
Year
Topic
Type